Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma

Blood. 2006 Feb 15;107(4):1731-2. doi: 10.1182/blood-2005-09-3731.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Disease Progression
  • Female
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / therapy
  • Humans
  • Male
  • Middle Aged
  • Pyrazines / therapeutic use*
  • Recurrence
  • Stem Cell Transplantation
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib